Vorapaxar in patients with peripheral artery disease and acute coronary syndrome: Insights from Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER)

American Heart Journal

Volumn 168, Issue 4, 2014, Pages 588-596

  Jones, William Schuyler ^a   Tricoci, Pierluigi ^a   Huang, Zhen ^a   Moliterno, David J ^b   Harrington, Robert A ^c   Sinnaeve, Peter R ^d   Strony, John ^e   Van De Werf, Frans ^d   White, Harvey D ^f   Held, Claes ^g   Armstrong, Paul W ^h   Aylward, Philip E ⁱ   Chen, Edmond ^j   Patel, Manesh R ^a   Mahaffey, Kenneth W ^c  

^a DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF LEUVEN   (Belgium)

^e MERCK RESEARCH LABORATORIES   (United States)

^f AUCKLAND CITY HOSPITAL   (New Zealand)

^g UPPSALA UNIVERSITY   (Sweden)

^h UNIVERSITY OF ALBERTA   (Canada)

ⁱ FLINDERS UNIVERSITY   (Australia)

^j Bayer HealthCare Pharmaceuticals Inc   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; VORAPAXAR; LACTONE; PYRIDINE DERIVATIVE; THROMBIN RECEPTOR;

ADULT; AGED; ARTICLE; BLEEDING; CARDIOVASCULAR MORTALITY; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; CORONARY ARTERY RECANALIZATION; DRUG EFFICACY; DRUG SAFETY; FEMALE; HEART INFARCTION; HUMAN; ISCHEMIA; LEG AMPUTATION; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; NON ST SEGMENT ELEVATION ACUTE CORONARY SYNDROME; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; ACUTE CORONARY SYNDROME; AMPUTATION; ANTAGONISTS AND INHIBITORS; CLINICAL TRIAL; COMPLICATION; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; ELECTROCARDIOGRAPHY; FOLLOW UP; HEART MUSCLE REVASCULARIZATION; MIDDLE AGED; MULTICENTER STUDY; PERIPHERAL ARTERIAL DISEASE; RETROSPECTIVE STUDY; TREATMENT OUTCOME; UTILIZATION;

ACUTE CORONARY SYNDROME; AGED; AMPUTATION; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; LACTONES; MALE; MIDDLE AGED; MYOCARDIAL REVASCULARIZATION; PERIPHERAL ARTERIAL DISEASE; PYRIDINES; RECEPTORS, THROMBIN; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84922218802     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2014.06.017     Document Type: Article

References (20)

1. D.L. Bhatt, A.M. Lincoff, and C.M. Gibson Intravenous platelet blockade with cangrelor during PCI N Engl J Med 361 2009 2330 2341
2. R.A. Harrington, G.W. Stone, and S. McNulty Platelet inhibition with cangrelor in patients undergoing PCI N Engl J Med 361 2009 2318 2329
3. D.L. Bhatt, K.A. Fox, and W. Hacke Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events N Engl J Med 354 2006 1706 1717
4. E.J. Topol, M.G. Bousser, and K.A. Fox Rimonabant for prevention of cardiovascular events (CRESCENDO): a randomised, multicentre, placebo-controlled trial Lancet 376 2010 517 523
5. D.A. Morrow, E. Braunwald, and M.P. Bonaca Vorapaxar in the secondary prevention of atherothrombotic events N Engl J Med 366 2012 1404 1413
6. P.P. Cacoub, D.L. Bhatt, and P.G. Steg Patients with peripheral arterial disease in the CHARISMA trial Eur Heart J 30 2009 192 201
7. J.S. Berger, M.J. Krantz, and J.M. Kittelson Aspirin for the prevention of cardiovascular events in patients with peripheral artery disease: a meta-analysis of randomized trials JAMA 301 2009 1909 1919
8. CAPRIE Steering Committee A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee Lancet 348 1996 1329 1339
9. E.M. Mahoney, K. Wang, and H.H. Keo Vascular hospitalization rates and costs in patients with peripheral artery disease in the United States Circ Cardiovasc Qual Outcomes 3 2010 642 651
10. M.R. Jaff, K.E. Cahill, and A.P. Yu Clinical outcomes and medical care costs among medicare beneficiaries receiving therapy for peripheral arterial disease Ann Vasc Surg 24 2010 577 587
11. P.P. Goodney, A.W. Beck, and J. Nagle National trends in lower extremity bypass surgery, endovascular interventions, and major amputations J Vasc Surg 50 2009 54 60
12. M.T. Abola, D.L. Bhatt, and S. Duval Fate of individuals with ischemic amputations in the REACH Registry: three-year cardiovascular and limb-related outcomes Atherosclerosis 221 2012 527 535
13. W.S. Jones, M.R. Patel, and D. Dai High mortality risks after major lower extremity amputation in Medicare patients with peripheral artery disease Am Heart J 165 2013 809 815 [815.e1]
14. M.P. Bonaca, B.M. Scirica, and M.A. Creager Vorapaxar in patients with peripheral artery disease: results from TRA2{degrees}P-TIMI 50 Circulation 127 2013 1522 1529 [1529e1-6]
15. P. Tricoci, Z. Huang, and C. Held Thrombin-receptor antagonist vorapaxar in acute coronary syndromes N Engl J Med 366 2012 20 33
16. TRA∗CER Executive and Steering Committees The Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRA∗CER) trial: study design and rationale Am Heart J 158 2009 327 334.e4
17. D.L. Bhatt, E.D. Peterson, and R.A. Harrington Prior polyvascular disease: risk factor for adverse ischaemic outcomes in acute coronary syndromes Eur Heart J 30 2009 1195 1202
18. G. Cotter, C.P. Cannon, and C.H. McCabe Prior peripheral arterial disease and cerebrovascular disease are independent predictors of adverse outcome in patients with acute coronary syndromes: are we doing enough? Results from the Orbofiban in Patients with Unstable Coronary Syndromes-Thrombolysis In Myocardial Infarction (OPUS-TIMI) 16 study Am Heart J 145 2003 622 627
19. J.B. Froehlich, D. Mukherjee, and A. Avezum Association of peripheral artery disease with treatment and outcomes in acute coronary syndromes. The Global Registry of Acute Coronary Events (GRACE) Am Heart J 151 2006 1123 1128
20. S. Subherwal, D.L. Bhatt, and S. Li Polyvascular disease and long-term cardiovascular outcomes in older patients with non-ST-segment-elevation myocardial infarction Circ Cardiovasc Qual Outcomes 5 2012 541 549